TechnologyOne share price rises on cyber incident update

Here's the latest on TechnologyOne's investigation.

| More on:
A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • On Wednesday, the market learned that TechnologyOne had suffered a cyber incident
  • The tech company told investors today that its affected systems had been restored and were fully operational
  • Cyber experts have confirmed that the systems are secure

The TechnologyOne Ltd (ASX: TNE) share price is currently up 1.64%, trading at $14.90 after the ASX tech share gave an update today regarding its cyber incident.

Earlier this week, the company entered a trading halt upon discovering that a third party accessed its internal Microsoft 365 back-office system.

TechnologyOne today sought to reassure the market about what was going on and what its investigation had uncovered.

In its announcement to the ASX, the company reminded investors that it acted immediately to investigate the issue.

TechnologyOne advised it had initiated its cyber response strategy. This included appointing "leading security and forensic experts, among other specialists, to work through containment measures".

What TechnologyOne knows so far

The company reiterated that its customer-facing software as a service (SaaS) platform was "not connected to the Microsoft 365 system and therefore has not been impacted". It added:

TechnologyOne reaffirms that its internal back-office system was isolated to contain the incident, that the system was successfully restored and is fully operational.

Subsequently, third-party cybersecurity experts have confirmed our Microsoft 365 system is secure and there has been no further illegal activity detected.

The company advised its focus remained on the investigation to determine what data may have been accessed. It will then engage with any impacted individuals on "appropriate actions".

In a bid to further reassure customers and investors, the company said:

TechnologyOne maintains administrative information on its back-office system. The information held by TechnologyOne on its back-office system is separate to customer's information and data on
TechnologyOne's SaaS platform, which is safe and secure.

As the investigation progresses and further facts are established, the company will "continue to keep all relevant stakeholders updated".

What happens next?

TechnologyOne will update the market on its performance and outlook when it releases its FY23 half-year result on 23 May 2023 — only a couple of weeks away.

Considering the TechnologyOne share price is in the green today, investors don't appear too concerned by the cyber incident.

This is in contrast to the cyber attack on Medibank Private Limited (ASX: MPL) in October last year. The Medibank share price fell materially, as demonstrated in the chart below, when it returned to trading following the attack.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »